February, 19th - 1 year ago
The report "Global Flow Cytometry Market”: - By Type of Product (Instruments, Softwares, Fluorospheres, Instrument Support Reagents, Reagents, Systems and Kits, and Others); By Technology (Bead based Flow Cytometry, Cell based Flow Cytometry and Others); By Application (Life Sciences and Biotechnology, Clinical Applications, and Others); By End-Users (CRO, Pharmaceuticals, Biotechnology, Hospitals, and Others); & By Geography (North America, Europe, Asia Pacific, South America, Middle East & Africa) - Forecast (2018-2024). Envision Intelligence estimates that Global Flow Cytometry Market size is projected to reach with $7.9 billion by the end of 2024 with a CAGR of 10.68% from $3.29 billion in 2018. Flow cytometers are the automated instruments that quantitate properties of single cells, one cell at a time. They can measure cell size, cell granularity, the amounts of cell components such as total DNA, newly synthesized DNA, gene expression as the amount messenger RNA for a particular gene, amounts of specific surface receptors, amounts of intracellular proteins, or transient signaling events in living cells. Quantities are usually relative but can be numbers of molecules per cell when absolute values are needed. Typically, up to three to six properties or components are quantitated in a single sample, cell by cell, for about 10,000 cells, in less than one minute (not counting time to prepare the sample, which might be an hour or more). Download Free Sample Brochure at https://www.envisioninteligence.com/industry-report/global-flow-cytometry-market/ Cell-based flow cytometry segment is expected to have the largest share in global flow cytometry during the forecast period. Cell-based flow cytometry would constitute the highest revenue generating segment throughout the forecast period due to its widespread use across all the applications. In this segment, Cell components are fluorescently labelled and then excited by the laser to emit light at varying wavelengths. Life Sciences and Biotechnology segment is expected to have largest market size during the forecast period. Life Sciences and Biotechnology applications segment is expected to account for the largest global flow cytometry share in the market, by an application. The Life Sciences and Biotechnology applications segment is further sub-segmented into Intracellular Calcium flux, Cell Proliferation Assay, Apoptosis, Cell cycle analysis, Cell Sorting, and Immunophenotyping. Asia-Pacific is projected to hold the fastest growth in the market during the forecast period. From the Global Flow Cytometry analysis, the market is segmented by region into North America, South America, Europe, Middle East & Africa, and Asia-Pacific. Asia-Pacific is expected to grow at the highest rate during the forecast period from 2018 to 2024 because of improving healthcare infrastructure, favorable government initiatives in Asia-Pacific region, and growing focus of market players on the Asia-Pacific flow cytometry market. Increasing level of process automation, Outsourcing of drug discovery process, and Increase in M&A are the three global flow cytometry trends driving the market. Key players in the market include: Beckman Coulter Thermo Fisher Scientific, Inc. Luminex Corporation Bio-Rad Laboratories Sony Biotechnology Inc.